Opinions of French psychiatrists on the regulatory status of cannabis: Results from the "PsyCan - Encéphale" national online survey.

IF 1.2 4区 医学 Q4 NEUROSCIENCES
Léa Leclerc, Eric Fakra, Baptiste Pignon, Amine Benyamina, Raphaël Gaillard, Benjamin Rolland
{"title":"Opinions of French psychiatrists on the regulatory status of cannabis: Results from the \"PsyCan - Encéphale\" national online survey.","authors":"Léa Leclerc, Eric Fakra, Baptiste Pignon, Amine Benyamina, Raphaël Gaillard, Benjamin Rolland","doi":"10.1016/j.encep.2023.11.008","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To explore the opinions of French psychiatrists toward the legalization of medical or recreational use of cannabis in France.</p><p><strong>Methods: </strong>Psycan was an anonymous Internet survey conducted between September 28, 2021 and March 29, 2022, among subscribers of the Encéphale Online community, i.e., approximately 4000 French psychiatrists. Participants were asked to complete a structured questionnaire, collecting their socio-demographic features, clinical experience, opinions toward cannabis legalization, and perceived impact of cannabis derivatives for psychiatric disorders. Logistic regression models were used to identify factors associated with being for or against cannabis legalization.</p><p><strong>Results: </strong>In total, 413 psychiatrists answered the survey, of whom 253 (61.3%) declared being in favour of recreational cannabis, and 349 (84.4%) of medical cannabis. Being in favour of legalization of recreational cannabis was negatively associated with being female (odd ratio [OR]=0.61; 95% confidence interval [CI]=0.41-0.93), and with the frequency of meeting patients with cannabis use disorder (OR=0.60; 95%CI=0.43-0.83). Most respondents were concerned about the development of psychotic disorders. The most frequent pro-legalization arguments were improved prevention, better control of product content, and better protection of youth, respectively. Arguments against legalization were increased societal damages, increased impact on health, including mental health.</p><p><strong>Conclusions: </strong>A majority of French psychiatrists were in favour of the marketing of medical cannabis, and, to a lesser extent, the legalization of recreational cannabis. For recreational cannabis, the proportion of pro-legalization psychiatrists was slightly more elevated than that found in the French general population.</p>","PeriodicalId":51042,"journal":{"name":"Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2024-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.encep.2023.11.008","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To explore the opinions of French psychiatrists toward the legalization of medical or recreational use of cannabis in France.

Methods: Psycan was an anonymous Internet survey conducted between September 28, 2021 and March 29, 2022, among subscribers of the Encéphale Online community, i.e., approximately 4000 French psychiatrists. Participants were asked to complete a structured questionnaire, collecting their socio-demographic features, clinical experience, opinions toward cannabis legalization, and perceived impact of cannabis derivatives for psychiatric disorders. Logistic regression models were used to identify factors associated with being for or against cannabis legalization.

Results: In total, 413 psychiatrists answered the survey, of whom 253 (61.3%) declared being in favour of recreational cannabis, and 349 (84.4%) of medical cannabis. Being in favour of legalization of recreational cannabis was negatively associated with being female (odd ratio [OR]=0.61; 95% confidence interval [CI]=0.41-0.93), and with the frequency of meeting patients with cannabis use disorder (OR=0.60; 95%CI=0.43-0.83). Most respondents were concerned about the development of psychotic disorders. The most frequent pro-legalization arguments were improved prevention, better control of product content, and better protection of youth, respectively. Arguments against legalization were increased societal damages, increased impact on health, including mental health.

Conclusions: A majority of French psychiatrists were in favour of the marketing of medical cannabis, and, to a lesser extent, the legalization of recreational cannabis. For recreational cannabis, the proportion of pro-legalization psychiatrists was slightly more elevated than that found in the French general population.

法国精神科医生对大麻监管地位的看法:PsyCan - Encéphale "全国在线调查结果。
目的:探讨法国精神病学家对法国医疗或娱乐使用大麻合法化的看法:探讨法国精神病学家对法国医疗或娱乐使用大麻合法化的看法:Psycan 是一项匿名网络调查,于 2021 年 9 月 28 日至 2022 年 3 月 29 日期间在 Encéphale 在线社区的用户(即约 4000 名法国精神科医生)中进行。调查要求参与者填写一份结构化问卷,收集他们的社会人口特征、临床经验、对大麻合法化的看法以及大麻衍生物对精神疾病的认知影响。采用逻辑回归模型确定与支持或反对大麻合法化相关的因素:共有 413 名精神科医生回答了调查,其中 253 人(61.3%)表示赞成娱乐用大麻,349 人(84.4%)表示赞成医用大麻。赞成娱乐用大麻合法化与女性(奇数比 [OR]=0.61; 95% 置信区间 [CI]=0.41-0.93 )和与大麻使用障碍患者见面的频率(OR=0.60; 95%CI=0.43-0.83 )呈负相关。大多数受访者对精神障碍的发展表示担忧。支持合法化的最常见理由分别是加强预防、更好地控制产品内容和更好地保护青少年。反对合法化的理由则是增加社会损失、增加对健康(包括精神健康)的影响:大多数法国精神科医生赞成医用大麻的市场化,其次是娱乐用大麻的合法化。就娱乐用大麻而言,支持大麻合法化的精神科医生比例略高于法国普通人群。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.60
自引率
7.40%
发文量
162
审稿时长
6-12 weeks
期刊介绍: Une revue française de renommée internationale. - Un comite de rédaction représentant tous les aspects de la prise en charge psychiatrique du patient. - Une sélection rigoureuse d''articles faisant l''objet de plusieurs expertises. - Des travaux d''auteurs et de chercheurs de renommée internationale. - Des indexations dans les grandes bases de données (Current Contents, Excerpta Medica, etc.). - Un facteur d''impact qui témoigne de la grande notoriété de la revue. La tribune des publications originales de haut niveau. - Une très grande diversité des sujets traités, rigoureusement sélectionnés à travers des sommaires dynamiques : - des éditoriaux de médecins référents, - une revue de presse sur les actualités internationales, - des articles originaux pour approfondir vos connaissances, - des mises au point et des cas cliniques pour engager votre réflexion sur les indications et choix possibles au travers de mises en situation clinique, - des dossiers thématiques pour faire le tour d''une question. - L''actualité de l''AFPB : L''Encéphale publie régulièrement des comptes rendus de l''Association française de psychiatrie clinique.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信